Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Iovance Biotherapeutics Inc IOVA

Healthcare Biotechnology
Iovance Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company develops and delivers tumor infiltrating lymphocyte (TIL), therapies for patients with solid tumor cancers. Its lead product candidate, Amtagvi (lifileucel), is a tumor-derived autologous T cell immunotherapy indicated for the treatment of adult patients with unresectable or metastatic melanoma previously... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:IOVA)

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024

GlobeNewswire November 7, 2024

Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024

GlobeNewswire October 31, 2024

Iovance Biotherapeutics to Present at Upcoming Conferences

GlobeNewswire September 3, 2024

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire August 16, 2024

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024

GlobeNewswire August 8, 2024

Iovance Biotherapeutics to Host Second Quarter and First Half 2024 Financial Results Conference Call and Webcast on Thursday, August 8, 2024

GlobeNewswire July 29, 2024

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire July 19, 2024

Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma

GlobeNewswire June 28, 2024

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire June 21, 2024
View More News ››

Opinion & Analysis (NDAQ:IOVA)

Iovance Biotherapeutics Shares Rise 12% on Updated Phase 2 Melanoma Study Results

Streetwise Reports November 12, 2019

Preliminary Phase 2 clinical data provides 'first spark to game-changing thesis'

Streetwise Reports January 31, 2018

Cell therapy for melanoma impresses in Phase 2

The Life Sciences Report August 10, 2017
View More Opinion ››

Bullboard Posts (NDAQ:IOVA)

2 Innovative Stocks That Could Deliver Outsize Returns

JUST IN: $IOVA 2 Innovative Stocks That Could Deliver Outsize Returns2024-11-22 10:00:00 ET Many of Wall Street's largest and most...
whytestocks - 3 hours ago

Neutral Recommendation Issued On IOVA By Piper Sandler

BREAKING NEWS: $IOVA Neutral Recommendation Issued On IOVA By Piper Sandler2024-07-29 05:15:07 ET Piper Sandler analyst issues NEUTRAL...
whytestocks - July 29, 2024

IOVA Price Target Alert: $10.00. Issued by Piper Sandler

BREAKING NEWS: $IOVA IOVA Price Target Alert: $10.00. Issued by Piper Sandler2024-07-29 05:00:08 ET Joseph Catanzaro from Piper Sandler...
whytestocks - July 29, 2024

Today's Big Lunch Trades 21 Feb 2024

NEWS: $IOVA Today's Big Lunch Trades 21 Feb 20242024-02-21 13:09:13 ET DENVER, Colo., Feb 21, 2024 (www.247marketnews.com)- Midday...
whytestocks - February 21, 2024

Iovance Biotherapeutics Hits New 52-Week High

JUST IN: $IOVA Iovance Biotherapeutics Hits New 52-Week High2024-02-21 11:42:05 ET DENVER, Colo., Feb 21, 2024 (www.247marketnews.com...
whytestocks - February 21, 2024

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) Near Top of Volu

NEWS: $IOVA Iovance Biotherapeutics Inc. (NASDAQ: IOVA) Near Top of Volume Charts in Tuesday TradingIovance Biotherapeutics, Inc...
whytestocks - February 20, 2024
View more Bullboard ››

TAG Oil Ltd.

TAG Oil Ltd.

TAG Oil Ltd. is an international oil and gas exploration company with a focus on operations and opportunities in the Middle ...
View More »